NO20004906L - PDE IV-inhiberende pyridinderivater - Google Patents

PDE IV-inhiberende pyridinderivater

Info

Publication number
NO20004906L
NO20004906L NO20004906A NO20004906A NO20004906L NO 20004906 L NO20004906 L NO 20004906L NO 20004906 A NO20004906 A NO 20004906A NO 20004906 A NO20004906 A NO 20004906A NO 20004906 L NO20004906 L NO 20004906L
Authority
NO
Norway
Prior art keywords
pde
pyridine derivatives
inhibiting
inhibiting pyridine
derivatives
Prior art date
Application number
NO20004906A
Other languages
English (en)
Other versions
NO319531B1 (no
NO20004906D0 (no
Inventor
Eddy Jean Edgard Freyne
Gaston Stanislas Marcell Diels
Maria Enc Matesanz-Ballesteros
Adolfo Diaz-Martinez
Original Assignee
Janssen Pharmaceutica Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Janssen Pharmaceutica Nv filed Critical Janssen Pharmaceutica Nv
Publication of NO20004906D0 publication Critical patent/NO20004906D0/no
Publication of NO20004906L publication Critical patent/NO20004906L/no
Publication of NO319531B1 publication Critical patent/NO319531B1/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
    • A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D407/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00
    • C07D407/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing three or more hetero rings

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pulmonology (AREA)
  • Immunology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Dermatology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pyridine Compounds (AREA)
NO20004906A 1998-04-01 2000-09-29 PDE IV-inhiberende pyridinderivater, deres fremstilling og anvendelse, samt sammensetninger omfattende dem NO319531B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP98201020 1998-04-01
PCT/EP1999/002045 WO1999050262A1 (en) 1998-04-01 1999-03-24 Pde iv inhibiting pyridine derivatives

Publications (3)

Publication Number Publication Date
NO20004906D0 NO20004906D0 (no) 2000-09-29
NO20004906L true NO20004906L (no) 2000-11-28
NO319531B1 NO319531B1 (no) 2005-08-29

Family

ID=8233543

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20004906A NO319531B1 (no) 1998-04-01 2000-09-29 PDE IV-inhiberende pyridinderivater, deres fremstilling og anvendelse, samt sammensetninger omfattende dem

Country Status (33)

Country Link
US (1) US6656959B1 (no)
EP (1) EP1068194B1 (no)
JP (1) JP4778612B2 (no)
KR (1) KR100596664B1 (no)
CN (1) CN1172930C (no)
AR (1) AR014972A1 (no)
AT (1) ATE253569T1 (no)
AU (1) AU760771B2 (no)
BG (1) BG64705B1 (no)
BR (1) BR9909326A (no)
CA (1) CA2326045C (no)
CZ (1) CZ298747B6 (no)
DE (1) DE69912590T2 (no)
DK (1) DK1068194T3 (no)
EA (1) EA004207B1 (no)
EE (1) EE04718B1 (no)
ES (1) ES2211061T3 (no)
HR (1) HRP20000619B1 (no)
HU (1) HU229412B1 (no)
ID (1) ID27207A (no)
IL (2) IL138745A0 (no)
MY (1) MY124696A (no)
NO (1) NO319531B1 (no)
NZ (1) NZ507022A (no)
PL (1) PL196026B1 (no)
PT (1) PT1068194E (no)
SI (1) SI1068194T1 (no)
SK (1) SK284468B6 (no)
TR (1) TR200002801T2 (no)
TW (1) TWI242558B (no)
UA (1) UA66842C2 (no)
WO (1) WO1999050262A1 (no)
ZA (1) ZA200006190B (no)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MY123585A (en) 2000-03-23 2006-05-31 Merck Canada Inc Tri-aryl-substituted-ethane pde4 inhibitors.
US6639077B2 (en) 2000-03-23 2003-10-28 Merck Frosst Canada & Co. Tri-aryl-substituted-ethane PDE4 inhibitors
DE10130397A1 (de) * 2001-06-23 2003-01-09 Bayer Cropscience Gmbh Herbizide substituierte Pyridine, Verfahren zu ihrer Herstellung und ihre Verwendung als Herbzide und Pflanzenwachstumsregulatoren
DE10318610A1 (de) * 2003-04-24 2004-11-11 Elbion Ag 7-Azaindole und deren Verwendung als Therapeutika
AU2005238296A1 (en) 2004-04-30 2005-11-10 Warner-Lambert Company Llc Substituted morpholine compounds for the treatment of central nervous system disorders
US7863446B2 (en) 2006-01-19 2011-01-04 Orchid Research Laboratories Limited Heterocycles
EP1987009A1 (en) 2006-01-30 2008-11-05 Euro-Celtique S.A. Cyclourea compounds as calcium channel blockers
SI2076508T1 (sl) 2006-10-18 2011-04-29 Pfizer Prod Inc Spojine biaril eter sečnine
JP5704924B2 (ja) 2008-02-01 2015-04-22 オーキッド リサーチ ラボラトリーズ リミティド 新規複素環化合物
JOP20190060A1 (ar) 2016-09-26 2019-03-26 Chugai Pharmaceutical Co Ltd مشتق بيرازولو بيريدين له تأثير مساعد لمستقبل glp-1

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3876657A (en) * 1971-06-03 1975-04-08 Ashland Oil Inc Preparation of 1-substituted-2-imidazolidinones
US4600430A (en) 1985-02-22 1986-07-15 Eli Lilly And Company Pyridinylimidazolidinone compounds
ES2176251T3 (es) * 1993-07-28 2002-12-01 Aventis Pharma Ltd Compuestos utilizados como inhibidores de pde iv y del factor de necrosis tumoral(tnf).
GB9401460D0 (en) * 1994-01-26 1994-03-23 Rhone Poulenc Rorer Ltd Compositions of matter
AU3272195A (en) * 1994-08-03 1996-03-04 Gics & Vermee, L.P. Ovenable food package
TW332201B (en) * 1995-04-06 1998-05-21 Janssen Pharmaceutica Nv 1,3-Dihydro-1-(phenylalkyl)-2H-imidazol-2-one derivatives
TW375612B (en) * 1995-04-06 1999-12-01 Janssen Pharmaceutica Nv 1,3-dihydro-2H-imidazol-2-one derivatives for the treatment of disease states related to an abnormal enzymatic or catalytic activity of phosphodiesterase type IV, preparation thereof and pharmaceutical composition containing the same
TW424087B (en) * 1995-04-06 2001-03-01 Janssen Pharmaceutica Nv 1,3-dihydro-1-(phenylalkenyl)-2H-imidazol-2-one derivatives
WO1997003967A1 (en) * 1995-07-22 1997-02-06 Rhone-Poulenc Rorer Limited Substituted aromatic compounds and their pharmaceutical use
CN1209060A (zh) * 1995-12-29 1999-02-24 史密丝克莱恩比彻姆公司 玻连蛋白受体拮抗剂
UA62939C2 (uk) 1996-10-02 2004-01-15 Янссен Фармацевтика Н.В. Похідне 2-ціаноіміноімідазолу, фармацевтична композиція та спосіб одержання сполуки

Also Published As

Publication number Publication date
JP4778612B2 (ja) 2011-09-21
AU760771B2 (en) 2003-05-22
CA2326045A1 (en) 1999-10-07
NO319531B1 (no) 2005-08-29
NO20004906D0 (no) 2000-09-29
TR200002801T2 (tr) 2000-12-21
AU3147499A (en) 1999-10-18
CA2326045C (en) 2008-12-09
ZA200006190B (en) 2001-10-31
CN1295571A (zh) 2001-05-16
AR014972A1 (es) 2001-04-11
TWI242558B (en) 2005-11-01
DE69912590T2 (de) 2004-09-16
BG64705B1 (bg) 2005-12-30
PL343194A1 (en) 2001-07-30
PL196026B1 (pl) 2007-11-30
SK284468B6 (sk) 2005-04-01
HRP20000619A2 (en) 2001-10-31
EA200001009A1 (ru) 2001-02-26
ID27207A (id) 2001-03-08
CZ298747B6 (cs) 2008-01-16
IL138745A (en) 2007-06-17
JP2002509927A (ja) 2002-04-02
CZ20003338A3 (cs) 2001-02-14
HUP0101239A2 (hu) 2002-05-29
ES2211061T3 (es) 2004-07-01
SK13872000A3 (sk) 2001-11-06
NZ507022A (en) 2002-06-28
WO1999050262A1 (en) 1999-10-07
MY124696A (en) 2006-06-30
KR100596664B1 (ko) 2006-07-06
EP1068194A1 (en) 2001-01-17
US6656959B1 (en) 2003-12-02
DK1068194T3 (da) 2004-03-15
HU229412B1 (en) 2013-12-30
PT1068194E (pt) 2004-03-31
KR20010040681A (ko) 2001-05-15
ATE253569T1 (de) 2003-11-15
IL138745A0 (en) 2001-10-31
EE04718B1 (et) 2006-10-16
HK1033579A1 (en) 2001-09-07
BG104718A (en) 2001-04-30
CN1172930C (zh) 2004-10-27
DE69912590D1 (de) 2003-12-11
HUP0101239A3 (en) 2002-09-30
UA66842C2 (uk) 2004-06-15
EE200000569A (et) 2002-04-15
EA004207B1 (ru) 2004-02-26
EP1068194B1 (en) 2003-11-05
HRP20000619B1 (en) 2004-06-30
BR9909326A (pt) 2000-12-12
SI1068194T1 (en) 2004-04-30

Similar Documents

Publication Publication Date Title
HRP20030306A2 (en) Pyridine derivatives with ikb-kinase (ikk-?) inhibiting activity
DE69839398D1 (de) Pyridinderivate
IS5197A (is) Nikótínamíð afleiður
ATE256123T1 (de) Pyrimidonderivate
NO20013003D0 (no) Kinolin-derivater
ATE228505T1 (de) Chinolinderivate
ATE250036T1 (de) Chinolinderivate
NO20021077D0 (no) Amino-triazolopyridin-derivater
ATE293104T1 (de) Thiazolylamid-derivate
ATE263748T1 (de) Admantan-derivate
ATE229005T1 (de) Chinolinderivate
DE50013404D1 (de) Substituierte 2-dialkylaminoalkylbiphenyl-derivate
NO991560L (no) PDE IV-inhiberende 2-cyanoiminoimidazol-derivater
ATE257148T1 (de) Propargyletherderivate
ATE374747T1 (de) Monofluoralkylderivate
ATE273272T1 (de) Mevinolinderivate
ATE293592T1 (de) Resorcinderivate
ATE254598T1 (de) 4-hydroxybiphenylhydrazid-derivate
DK1068194T3 (da) PDE IV-hæmmende pyridinderivater
DE60025348D1 (de) Ethansulfonyl-piperidin-derivate
DE60001736D1 (de) 1-trifluorotmethyl-4-hydroxy-7-piperidinyl-aminomethylchroman-derivate
ATE269328T1 (de) 1-cycloalkylpyrazolyl-benzoyl-derivate
ATE365723T1 (de) Il-5 hemmende 6-uracilderivate
ATE259816T1 (de) Tricyclische benzoylcyclohexandion-derivate
PT1065205E (pt) Derivados heteroaromaticos

Legal Events

Date Code Title Description
MK1K Patent expired